Lv6
1706 积分 2024-05-16 加入
A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
1天前
已完结
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
2天前
已完结
DLL4/VEGF bispecific molecularly imprinted nanomissile for robust tumor therapy
1个月前
已完结
Mass Spectral Analyses of Labile DOTA-NHS and Heterogeneity Determination of DOTA or DM1 Conjugated Anti-PSMA Antibody for Prostate Cancer Therapy
3个月前
已完结
Synthesis and Evaluation of [177Lu]Lu-Labeled-NLS-Trastuzumab Conjugate for Targeting of HER2 Positive Metastatic Breast Cancer: Evaluating the Effect on Intracellular Localization
3个月前
已完结
Radioligand–Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis
3个月前
已完结
Next Generation of Solid Target Radionuclide Antibody Conjugates for Tumor Immuno‐Therapy
3个月前
已完结
A Bispecific Peptide–Drug Conjugate Targeting LAG-3 and PD-L1 Harnesses Antitumor Immunity of Macrophages and T Cells
4个月前
已完结
The emerging role of lymphocyte‐activation gene 3 targeting in the treatment of solid malignancies
4个月前
已完结
Crystal structure of the human LAG-3–HLA-DR1–peptide complex
4个月前
已完结
皖公网安备34019202002308
